Tevogen Inc. Regains Nasdaq Compliance for $15M Market Value

What Happened Tevogen Inc. announced on Form 8-K (filed Sept. 10, 2026) that on September 9, 2026 it received written notice from The Nasdaq Stock Market LLC confirming the company had regained compliance with the $15 million minimum market value of publicly held shares requirement under Nasdaq Listing Rule 5450(b)(2&3)(C) for continued listing on the Nasdaq Global Market. The notice states the matter is now closed.

Key Details

• Nasdaq notice dated: September 9, 2026.
• Form 8-K filed: September 10, 2026 (Accession: 0001493152-26-042095).
• Rule referenced: Nasdaq Listing Rule 5450(b)(2&3)(C) — $15 million minimum market value of publicly held shares.
• Outcome: Company regained compliance; no further action from Nasdaq indicated and the matter is closed.

Why It Matters Regaining compliance means Tevogen remains listed on the Nasdaq Global Market, avoiding a potential delisting action tied to the public float market value standard. For investors, continued listing supports ongoing trading liquidity and access to a major exchange, and reduces near-term regulatory uncertainty tied to that specific listing standard.